Shuttle Pharmaceuticals hosted special shareholder meeting, filings showed

• Shuttle Pharmaceuticals Holdings Inc. held a special shareholder meeting on Sept. 9, 2026.
• Shareholders authorized large issuances of common stock, preferred conversions, and pre-funded warrant exercises tied to a merger agreement.
• Investors also authorized additional common stock issuances tied to a separate securities purchase agreement, including preferred conversions and warrant exercises.
• An amendment to the 2018 Equity Incentive Plan was adopted, raising the share pool to 8,800,000.
• Stockholders adopted a charter amendment to rename the company United Compute Inc.; an adjournment proposal also passed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042299), on September 11, 2026, and is solely responsible for the information contained therein.